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Psychological disordersAbstract Background: COPD patients have to deal not only with the physical consequences of the
disease, but they must also deal with the psychological consequences of COPD. Anxiety and depres-
sion are highly prevalent co morbidities in COPD.
Objective: To assess the symptoms of depression and anxiety in COPD patients and to correlate
between the severity of the anxiety and depression with the severity of the COPD.
Subjects and methods: 80 COPD patients were assessed using SCID for establishing psychiatric
diagnosis, Beck depression inventory for assessment of the severity of depressive symptoms, Ham-
ilton anxiety scale for the severity of anxiety symptoms, Spirometry and arterial blood gases for
assessing the severity of COPD; and were matched to 80 healthy controls.
Results: The patient group showed higher statistically signiﬁcant difference in the presence of
psychiatric illness (55%, p= 0.001), anxiety level (22.5%, p= 0.06), depression level (42.5%,
p= 0.0001), and substance abuse (15%, p= 0.035). Anxiety and depressive scores were signiﬁ-
cantly associated with the severity of COPD (p< 0.001). Anxiety score correlated with age
(r= 0.267), and PaO2 (r= 0.326). Depression score correlated with FEV1 (r= 0.262).
Conclusion: This study proves the association between COPD and symptoms of anxiety and
depression. The severity of anxiety and depression were correlated with the severity of COPD
and the presence of lower PaO2. Age, sex, duration of illness and previous ICU admission or
mechanical ventilation did not correlate with depression or anxiety symptoms.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.
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Chronic obstructive pulmonary disease (COPD) is a major
cause of chronic morbidity and mortality throughout the
world and it is the fourth leading cause of death worldwide
[1]. Patients with COPD frequently ﬁnd themselves in a vicious
cycle of dyspnea, deteriorating exercise performance, restricted
mobility and social isolation [2].
COPD patients have to deal not only with the physical con-
sequences of the disease, but they must also deal with the psy-
chological consequences of COPD [3].
Anxiety and depression are highly prevalent co morbidities
in COPD [4]. Investigating anxiety and depression in COPD
patients is challenging because of the subjective nature of the
diagnostic process, the variability in presentation and the sig-
niﬁcant overlap of symptoms between COPD, anxiety and
depression (i.e. dyspnea, chest tightness, palpitations, tremor,
fatigue, disordered sleep and loss of appetite) [5,6].
Importantly, symptoms of anxiety and depression in COPD
were shown to be associated with a worse course of disease,
including reduced quality of life and increased symptoms bur-
den, health-care use, and even mortality [7].
Depression has always received greater attention in these
patients while, anxiety in COPD patients has received even less
attention than depression, despite the fact that anxiety and
depression usually occur together in these patients [4].
The mental disorders themselves can be further aggravated
by patients’ disabilities and, in turn, they can exaggerate
patients’ COPD symptoms. When recognized, they are,
however, treatable and should be treated since health is
regarded as a state of complete physical, social and mental
wellbeing [8].
The aim of the present study was to assess the symptoms of
depression and anxiety in COPD patients and to correlate be-
tween the severity of the anxiety and depression with the sever-
ity of the COPD.
Subjects and methods
This is a cross-sectional pilot study that was carried out in the
outpatient clinic and inpatient ward of the chest department,
Ain Shams University hospitals. One hundred sixty candidates
participated in the study. They were 80 COPD patients (diag-
nosed according to GOLD 2013 [9]) and 80 matched healthy
subjects as a control group.
All patients were subjected to:
– Full history taking with concern to duration of the illness,
prior admission to intensive care, oxygen therapy or
mechanical ventilation as added stressors that may contrib-
ute to different psychological outcomes.
– Thorough clinical examination.
– Chest X-ray and CT chest if needed.
– Spirometric assessment (using Flowscreen Spirometer, Via-
sys) was done after administration of adequate dose of
short-acting inhaled bronchodilator to minimize variability.
– Classiﬁcation of severity of airﬂow limitation in COPD
(patients with FEV1/FVC < 0.7) was done based on post
bronchodilator FEV1, according to GOLD 2013 [9]:
 Mild COPD: FEV1 > 80% of predicted.
 Moderate COPD: 50% 6 FEV1P 80% of predicted. Severe COPD: 30% 6 FEV1P 50% of predicted.
 Very severe COPD: FEV1 < 30% of predicted.– Arterial blood gases (ABG) was done (using Radiometer
ABL 800 ﬂex) and patients were classiﬁed according to par-
tial pressure of arterial oxygen tension (PaO2) into: patients
with PaO2 > 80 mmHg, patients with PaO2 60–80 mmHg
and patients with PaO2 < 60 mmHg to ease the correlation
between different levels of PaO2 and other parameters.
Eighty healthy subjects with matched age, sex and socio-
economic conditions were recruited as a control group. They
were selected from the employees and visitors of patients com-
ing to the Ain Shams University hospitals in all departments.
All candidates were subjected to:
- Structured Clinical Interview for DSM IV axis I disorders
(SCID-I-Clinician version) [10]: The SCID has 7 diagnostic
modules, focused on different diagnostic groups: mood,
psychotic, substance abuse, anxiety, somatoform, eating
and adjustment disorders. Its use in this study was to ascer-
tain the presence of a psychiatric diagnosis; the clinician
version was used rather than the research version for its rel-
atively easier administration and coverage of the diagnoses
most commonly encountered in clinical settings.
- Hamilton anxiety scale (HAM-A) [11]: The HAM-A was
developed to measure the severity of anxiety symptoms,
and is still widely used today in both clinical and research
settings. The scale consists of 14 items, each deﬁned by a series
of symptoms, and measures both psychological anxiety
(mental agitation and psychological distress) and somatic
anxiety (physical complaints related to anxiety). A total score
of 0–17 is considered to be mild, 18–25 moderate, and 26–30
severe. Totals above 30 indicate very severe anxiety.
- Beck depression inventory (BDI) [12]: It measures the depth
and behavioral manifestations of depression and consists of
21 items, each of which has four responses of increasing
severity. Numerical values from 0–3 are assigned to each
statement to indicate the degree of severity. A total score
from 0–9 is considered normal, 10–16 reﬂects mild depres-
sion, 17–29 reﬂects moderate depression and 30 or above
is considered severe depression. It is a widely used stan-
dardized instrument.
Patients with other chest diseases, past history of psychiat-
ric disorders, past history of other chronic medical disorder as
diabetes mellitus, hypertension. . .etc. were excluded from the
study.Statistical analysis
Continuous variables are expressed as mean and Standard
Deviation. Categorical variables are expressed as frequencies
and percents. Student t test and ANOVA test was used to as-
sess the statistical signiﬁcance of the difference between two
and more than two study groups means respectively. Chi
Square and Fisher’s exact test were used to examine the rela-
tionship between Categorical variables. Pearson’s correlation
was used to assess the correlation between quantitative vari-
ables. Multivariate Linear regression was used to test and esti-
mate the dependence of a quantitative variable based on its
relationship with a set of independent variables a signiﬁcance
Assessment of depression in pulmonary disease patients 577level of P< 0.05 was used in all tests. All statistical procedures
were carried out using SPSS version 15 for Windows (SPSS
Inc, Chicago, IL, USA).
This study is the ﬁrst of 2 publications in a research project
assessing psychiatric symptomatology and cognitive functions
in COPD patients.
Results
The current study was conducted on 80 COPD patients diag-
nosed and their level of severity was determined according to
GOLD 2013. Eighty healthy age, sex and socio-economic
matched subjects were also included in the study as a control
group. The descriptive data of both groups are shown in
Table 1.
By using Student-t test and Chi-Square test in comparing
between COPD patients and control groups as regards per-
sonal data (age, gender, smoking habits, occupation, marital
state and residence), there was no statistical signiﬁcant differ-
ence between both groups.
Psychiatric characteristics in the form of presence or ab-
sence of psychiatric disorder, anxiety and depression scores
and levels of severity of them together with the presence or ab-
sence of substance abuse were described in the COPD patients
group and control group in Table 2.
This Table 3 shows a highly statistical signiﬁcant differ-
ence between COPD and control groups as regards theTable 1 Description of personal and clinical data in both COPD p
Age (years)
Duration of smoking (years)
Gender Male (n%)
Female (n%)
Smoking status Smoker (n%)
Non smoker (n%
Ex-smoker (n%)
Residence Cairo (n%)
Outside Cairo (n
Occupation (If exposed to respiratory irritant) No exposure (n%
Exposure (n%)
Marital status (single = divorced or widow) Married (n%)
Single (n%)
Duration of illness (years)
PaO2 (mmHg)
FEV1 (% of predicted)
Previous ICU admission Yes (n%)
No (n%)
No of ICU admission 1(n%)
2(n%)
3(n%)
4(n%)
Previous mechanical ventilation Yes (n%)
No (n%)
PaO2 levels >80 mmHg
60-80 mmHg
<60 mmHg
On oxygen therapy Yes (n%)
No (n%)presence of psychiatric disorder, depression score, severity
of depression and severity of anxiety. On the other hand,
there was no signiﬁcant difference in comparing both
groups as regards anxiety score, while substance abuse
showed signiﬁcant difference between both the COPD and
control groups.
The Table 4 showed a signiﬁcant negative t correlation be-
tween age and anxiety score (Fig. 1), on the other hand a direct
signiﬁcant correlation was found between PaO2 and anxiety
score (Fig. 2). FEV1 showed a signiﬁcant negative correlation
with depression score (Fig. 3).
There was no correlation between all personal data of the
groups (apart from age) and anxiety or depression scores.
In comparing between COPD cases with different severities
as regards personal and psychiatric data, there were more anx-
iety symptoms in patients with severe COPD compared to
other groups (p= 0.047), while patients with severe and very
severe COPD had more depressive symptoms compared to
other groups (p= 0.016) as shown in Table 5.
In comparing between cases with different levels of PaO2 as
regards age, duration of illness and psychiatric disorders
(Table 6) there was a highly signiﬁcant relationship between
the presence of depression and PaO2 levels 60–80 mmHg and
a signiﬁcant relationship between different levels of PaO2
and different levels of depression. On the other hand, there
was no signiﬁcant difference between different levels of PaO2
and age, duration of illness, substance abuse and the presenceatients and the control group.
Patients group Control group
Mean ±SD Mean ±SD
59.35 10.09 62.37 10.52
33.49 13.33 29.23 11.41
76 95.0% 74 92.5%
4 5.0% 6 7.5%
32 40.0% 32 40.0%
) 10 12.5% 20 25.0%
38 47.5% 28 35.0%
52 65.0% 60 75.0%
%) 28 35.0% 20 25.0%
) 60 75.0% 58 72.5%
20 25.0% 22 27.5%
60 75.0% 66 82.5%
20 25.0% 14 17.5%
17.18 9.29
65.62 15.90
51.36 15.55
26 32.5%
54 67.5%
10 38.5%
8 30.8%
6 23.1%
2 7.7%
8 10.0%
72 90.0%
22 27.5%
28 35.0%
30 37.5%
26 32.5%
54 67.5%
Table 2 Description of psychiatric characteristics among both patients and control groups.
Patients group Control group
Mean ±SD Mean ±SD
Anxiety score 11.77 4.91 10.53 3.28
Depression score 9.10 4.34 7.18 3.22
Present psychiatric disorder Yes (n%) 44 55.0% 16 20.0%
No (n%) 36 45.0% 64 80.0%
Anxiety level Normal (n%) 62 77.5% 72 90.0%
Mild 4 5.0% 6 7.5%
Moderate (n%) 14 17.5% 2 2.5%
Depression level Normal (n%) 46 57.5% 70 87.5%
Mild 28 35.0% 8 10.0%
Moderate (n%) 6 7.5% 2 2.5%
Substance Abuse Yes (n%) 12 15.0% 4 5.0%
No (n%) 68 85.0% 76 95.0%
Table 3 Comparison between cases and controls as regards psychiatric characteristics.
COPD group Control group P Sig
Mean ±SD Mean ±SD
Anxiety score 11.77 4.91 10.53 3.28 .06* NS
Depression score 9.10 4.34 7.18 3.22 .002* HS
Present psychiatric disorder Yes (n%) 44 55.0% 16 20.0% .0001** HS
No (n%) 36 45.0% 64 80.0%
Anxiety level (n%) Normal 62 77.5% 72 90.0% .006** HS
Mild 4 5.0% 6 7.5%
Moderate 14 17.5% 2 2.5%
Depression level (n%) Normal 46 57.5% 70 87.5% .0001*** HS
Mild 28 35.0% 8 10.0%
Moderate 6 7.5% 2 2.5%
Substance abuse Yes (n%) 12 15.0% 4 5.0% .035** S
No (n%) 68 85.0% 76 95.0%
* Student t test.
** Chi-Square test.
*** Fisher’s exact test.
Table 4 Correlations between personal data, medical data and psychiatric disorders among COPD cases.
Anxiety score Depression score
Age r -.267(*) -.063
P .017 .581
Sig S NS
Duration of smoking r .022 .226
P .854 .053
Sig NS NS
Duration of illness r -.147 .120
P .194 .288
Sig NS NS
Number of ICU admission r .358 .364
P .073 .067
Sig NS NS
PaO2 r .326 .175
P .003 .120
Sig HS NS
FEV1 r -.182 -.262
P .107 .019
Sig NS S
* = signiicant.
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Figure 1 Shows signiﬁcant negative correlation between age and
anxiety score.
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Figure 2 Shows a direct signiﬁcant correlation between PaO2
and anxiety score.
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Figure 3 Shows a signiﬁcant negative correlation between FEV1
and depression score.
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PaO2 levels.
In the present study the drug abusers showed no signiﬁcant
difference in anxiety and depression scores in comparison with
non drug abusers. Mean anxiety score was 10.5 ± 4.54 and12.0 ± 4.97 in drug abusers and non drug abusers respectively.
While, depression scores were 9.0 ± 4.75 and 9.12 ± 4.3
respectively.
Also in comparison between previously ICU admitted cases
and non ICU admitted cases as regards anxiety and depression
scores, the anxiety score was 10.92 ± 5.3 and 12.19 ± 4.71
respectively and the depression score was 10.0 ± 5.69 and
8.67 ± 3.5 respectively with no statistically signiﬁcant differ-
ence between both cases.
As regards cases with a history of mechanical ventilation
the mean anxiety score was 10.75 ± 2.05 and 11.89 ± 5.13
in cases with no history of mechanical ventilation respectively,
while the depression score was 10.5 ± 6.61 and 8.94 ± 4.05
respectively with no statistical signiﬁcance between both cases.
Also in the current study patients who received oxygen
therapy showed no signiﬁcant difference than patients who
did not receive oxygen therapy with anxiety scores of
10.83 ± 5.37 and 12.18 ± 4.69 respectively and depression
scores of 9.67 ± 5.54 and 8.86 ± 3.74 respectively.Discussion
Patients with COPD may experience a higher prevalence of
psychological distress, like symptoms of anxiety and depres-
sion, than the general healthy population [13]. Increasing evi-
dence suggests that anxiety and depression may have direct
impacts on health status, hospitalization and exacerbation
of COPD, rather than being consequences or markers of
disease severity. Thus, detecting depression or anxiety in
patients with COPD is of great importance [7]. Therefore,
the aim of the present study was to assess the symptoms of
depression and anxiety in COPD patients and to correlate be-
tween the severity of the anxiety and depression with the
severity of the COPD.
In the present study 44 patients out of 80 (55%) showed
psychiatric disorders, while in the control group 16 subjects
out of 80 (20%) showed psychiatric disorders. The most com-
mon psychiatric disorders were depression (42.5% in COPD
patients and 10% in control group) followed by anxiety
(22.5% in COPD group and 8% in control group), whereas
substance abuse was detected in 15% of COPD cases and in
5% of the control group.
This coincides with Regvat et al. [8] who investigated the
prevalence of anxiety and depression in 50 chronic obstructive
pulmonary disease (COPD) patients and found that 50% of
patients entering the rehabilitation program showed anxiety
and/or depression.
It also coincides with other investigators [14] who studied
the prevalence of anxiety and depression in 701 COPD patients
and found that about 41.8% of patients had anxiety and/or
depression symptoms.
Another study [15] agreed with our results and stated that
43% of COPD patients were diagnosed with depression and
29% of them were diagnosed with anxiety. It also agrees with
other studies [16,17] who stated that scores of depression and
anxiety were higher in the COPD patient in comparison with
the control group.
Our study showed that 15% of the COPD patients had sub-
stance abuse in comparison with 5% in the control group. This
coincides with another study [18] stated that 7.7% of COPD
patients had substance abuse disorders.
Table 5 Comparison between cases with different COPD severity as regards personal and psychiatric disorders.
Mild COPD Moderate COPD Severe COPD V. severe COPD P Sig
Mean ±SD Mean ±SD Mean ±SD Mean ±SD
Age 60.43 11.88 59.00 10.87 59.71 10.33 57.80 3.08 .929* NS
Duration of illness 15.14 5.01 16.29 9.59 17.71 10.77 21.00 8.43 .444* NS
PaO2 65.47 16.35 62.89 19.73 65.57 11.77 73.60 12.43 .346
* NS
Anxiety score 10.43 4.40 10.29 3.47 13.57 6.11 12.80 3.85 .047* Sa
Depression score 8.57 2.34 7.43 3.48 10.00 4.47 12.00 6.32 .016*b Sb
PaO2 >80 mmHg 2 14.3% 12 42.9% 4 14.3% 4 40.0% .0001
*** HS
60-80 10 71.4% 2 7.1% 12 42.9% 4 40.0%
<60 mmHg 2 14.3% 14 50.0% 12 42.9% 2 20.0%
Psychiatric disorder Yes 6 42.9% 16 57.1% 16 57.1% 6 60.0% .792** NS
No 8 57.1% 12 42.9% 12 42.9% 4 40.0%
Anxiety Normal 12 85.7% 24 85.7% 18 64.3% 8 80.0% .397*** NS
Mild 0 .0% 2 7.1% 2 7.1% 0 .0%
Moderate 2 14.3% 2 7.1% 8 28.6% 2 20.0%
Depression Normal 8 57.1% 18 64.3% 16 57.1% 4 40.0% .208*** NS
Mild 6 42.9% 10 35.7% 8 28.6% 4 40.0%
Moderate (n%) 0 .0% 0 .0% 4 14.3% 2 20.0%
Substance Abuse Yes 4 28.6% 4 14.3% 4 14.3% 0 .0% .334*** S
No 10 71.4% 24 85.7% 24 85.7% 10 100.0%
* ANOVA.
** Chi-Square test.
*** Fisher exact test.
a Gr3 Vs Gr1(S), Gr3 Vs Gr2(S) by Post Hoc test.
b Gr4 Vs Gr1(S), Gr4 Vs Gr 2(HS), Gr3 Vs Gr2(S) by Post Hoc test.
Table 6 Comparison between cases with different levels of PaO2 as regards age, duration of illness and psychiatric disorders.
PaO2 (>80 mmHg) PaO2 (60–80 mmHg) PaO2 (<60 mmHg) P Sig
Mean ±SD Mean ±SD Mean ±SD ±SD
Age 55.91 11.47 60.36 10.07 60.93 8.65 .168* NS
Duration of illness 15.45 7.69 17.79 8.63 17.87 10.94 .600* NS
Anxiety score 12.91 3.87 12.50 5.30 10.27 4.99 .099* NS
Depression score 8.55 3.58 11.14 4.37 7.60 4.20 .005* HSa
Psychiatric disorder (n%) Yes 12 54.5% 20 71.4% 12 40.0% .056** NS
No 10 45.5% 8 28.6% 18 60.0%
Anxiety (n%) Normal 14 63.6% 20 71.4% 28 93.3% .004*** HS
Mild 4 18.2% 0 .0% 0 .0%
Moderate 4 18.2% 8 28.6% 2 6.7%
Depression (n%) Normal 14 63.6% 10 35.7% 22 73.3% .02*** S
Mild 8 36.4% 14 50.0% 6 20.0%
Moderate 0 .0% 4 14.3% 2 6.7%
Substance abuse (n%) Yes 2 9.1% 6 21.4% 4 13.3% .533** NS
No 20 90.9% 22 78.6% 26 86.7%
* ANOVA.
** Chi-Square test.
*** Fisher exact test.
a Gr1 Vs Gr2(S), Gr2 Vs Gr3(HS) by Post Hoc test.
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COPD (according to GOLD 2013) showed signiﬁcantly
higher depression and anxiety scores in comparison with mild
and moderate COPD patients. There was also a signiﬁcant
negative correlation between depression severity and FEV1,
whereas anxiety severity showed no signiﬁcant correlation
with FEV1.
This agrees with Janssen et al., [14] who studied relevant
symptoms of anxiety and depression in 701 COPD patients
entering pulmonary rehabilitation and found that patientswith severe COPD had a signiﬁcantly higher depression and
anxiety scores than mild and moderate groups. Also in another
study [19] they stated that decreased FEV1 is correlated with
the development of depression and anxiety among COPD
patients.
Another study agreed with our study [17] and stated that in-
creased frequency of depression was associated with severity of
COPD. While anxiety frequency was not signiﬁcant among
COPD patients, its scores were higher among COPD patients
than in the controls.
Assessment of depression in pulmonary disease patients 581It also coincides to some extent with Lou et al., [20] who
stated that increased frequency of anxiety symptoms was cor-
related with increased COPD severity according to the GOLD
stages. However, they also found that no signiﬁcant difference
was observed between patients with or without depression or
anxiety regarding FEV1.
On the other hand, other study [14] showed no signiﬁcant
correlation between severity of COPD and scores of depression
and anxiety.
In the current study there was a highly signiﬁcant relation-
ship between the presence of depression and PaO2 level espe-
cially PaO2 level 60–80 mmHg and a signiﬁcant relationship
between different levels of PaO2 and different levels of depres-
sion. As regards anxiety the current study showed no signiﬁ-
cant correlation between the anxiety score and PaO2 level,
however there was a highly signiﬁcant direct correlation be-
tween PaO2 levels and severity levels of anxiety.
This coincides with other investigators [21] stated that pa-
tients with depression had lower PaO2 levels.
Also, coincides partially with Regvat et al., [15] who found
that depression and/or anxiety in COPD patients were associ-
ated with higher levels of PaO2. They suggested that this may
be explained as the patients with anxiety and/or depression are
referred and admitted to the hospital earlier in exacerbation.
On the other hand, other investigators [17,14] found that
there was no correlation between PaO2 levels and psychiatric
disorders.
In the present study duration of illness, history of ICU
admission, history of previous mechanical ventilation and oxy-
gen therapy did not show signiﬁcant correlation with depres-
sion or anxiety scores.
This coincides with another study [14] investigated the
symptoms of anxiety and depression COPD patients and sta-
ted that duration of COPD illness is not correlated with
depression or anxiety scores. Other investigators [20,21] who
studied the symptoms of anxiety and depression in COPD pa-
tients entering pulmonary rehabilitation found that oxygen
therapy has no signiﬁcance in depression or anxiety scores.
To some extent it also coincides [22] with other investiga-
tors who studied the prevalence of anxiety and depression in
COPD patients and associated factors, they found that previ-
ous admission to the emergency room is not correlated with
depression or anxiety.
On the other hand, another study [21] found that oxygen
therapy and non invasive mechanical ventilation showed sig-
niﬁcant correlation with symptoms of depression and anxiety
in COPD patients. Also, other investigators [23] found that pa-
tients stayed in ICU for different causes (average stay 8 days)
showed 20–30% mood disorders in the form of depression
and/or anxiety.
In the present study both patients and control groups were
matched as regards age, sex and socio-economic status. There
was no statistical signiﬁcance between both groups as regards
personal data (smoking habits, duration of smoking, marital
status, residence and occupation). There was no correlation be-
tween depression and anxiety scores with all these personal
data apart from age, as anxiety score showed negative correla-
tion with age.
This coincides, in most of personal data, with many studies
[14,15,21] stated that age, sex, occupation, residence and smok-
ing status has no correlation with depression and anxiety
symptoms in COPD patients.However, other studies mentioned [20,22] that females
were more common having depression and/or anxiety than
males. Some of these studies found that depression and anxiety
symptoms were associated with middle and older age and
increased in current smoking.
Finally, Obradovid et al. [17] stated that age and gender has
no signiﬁcance in depression, while smoking is related to
depression symptoms.Conclusions
This study proves the association between COPD and symp-
toms of anxiety and depression. The severity of anxiety
and depression were correlated with the severity of COPD and
the presence of lower PaO2. Age, sex, duration of illness and
previous ICU admission or mechanical ventilation did not
correlate with depression or anxiety symptoms.
It shows that it is important to screen for symptoms of anx-
iety and depression in COPD patients for possibility of depres-
sion and anxiety treatment which may improve the clinical
outcome of the patients. However, further studies are needed
for the impact of these disorders on the COPD course and
their effect on exacerbation, morbidity and mortality of the
disease. Also, studies are needed to investigate the effect of
depression and anxiety therapy on COPD patients and their
prognosis.Conﬂict of interest
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